{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 10,
  "authors": [
    {
      "name": "Ji Ma"
    },
    {
      "name": "Tao Wang"
    },
    {
      "name": "Yichen Zheng",
      "orcid": "0009-0007-8750-3119"
    },
    {
      "name": "Tonghui Ren"
    },
    {
      "name": "Dongdong Zhu"
    },
    {
      "name": "Yiwen Qiu"
    },
    {
      "name": "Yi Yang"
    },
    {
      "name": "Li Jiang"
    },
    {
      "name": "Shu Shen"
    },
    {
      "name": "Wentao Wang",
      "orcid": "0009-0002-2052-7160"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/1aqjjne599p91.bib",
  "cited_by": 0,
  "doi": "10.1038/s41467-026-78413-z",
  "fulltext_url": null,
  "id": "1aqjjne599p91",
  "issns": [
    "2041-1723"
  ],
  "landing_url": "https://www.nature.com/articles/s41467-026-78413-z",
  "language": null,
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2746|Cholangiocarcinoma and Gallbladder Cancer Studies"
    ]
  ],
  "openalex": "W7222914825",
  "pdf_url": "https://www.nature.com/articles/s41467-026-78413-z_reference.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-19",
  "publisher": "Springer Science and Business Media LLC",
  "ris": "https://research.draconitic.com/paper/1aqjjne599p91.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:39Z",
      "native_id": "10.1038/s41467-026-78413-z",
      "source": "crossref",
      "url": "https://www.nature.com/articles/s41467-026-78413-z"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2746|Cholangiocarcinoma and Gallbladder Cancer Studies",
      "subfield": "surgery"
    }
  ],
  "title": "Cadonilimab plus gemcitabine and cisplatin as first-line treatment for unresectable locally advanced or metastatic biliary tract malignancies: the phase II bicureX clinical trial",
  "title_text": "Cadonilimab plus gemcitabine and cisplatin as first-line treatment for unresectable locally advanced or metastatic biliary tract malignancies: the phase II bicureX clinical trial",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:39Z",
  "url": "https://research.draconitic.com/paper/1aqjjne599p91",
  "venue": "Nature Communications",
  "versions": []
}